What is HCG? Research and Australian laboratory supply

HCG is a glycoprotein hormone formed from an alpha subunit and an HCG-specific beta subunit. ^[1] The subunits are bound non-covalently; the alpha subunit is shared with luteinising hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH). ^[1] A single short peptide sequence does not describe this two-subunit structure. ^[1]

The placenta produces HCG during pregnancy. ^[7] Nebraska Medicine describes its early physiological role as signalling to the corpus luteum, which allows continued progesterone production. ^[7] Blood and urine assays measure HCG, so the hormone's name also appears in pregnancy-testing information. ^[8]

The Peptides Collective HCG 5000IU vial sits in our hormone research collection. ^[2] Its batch certificate is available on request. ^[3] The vial's declared content and the compound's molecular identifiers are separate checks; the certificate request should identify the compound, strength and batch number. ^[3]

HCG research in the selected literature includes review papers on biological functions and obesity research, plus a human study of FSH/HCG in men with idiopathic hypogonadotropic hypogonadism. ^[4][9][5] The study model and population define what each source can tell a researcher. ^[4][5]

No standalone cell or animal study is included in the HCG evidence assembled for this overview. ^[4] That is a limit of the selected sources; cell or animal research may exist elsewhere. ^[4]

For a laboratory purchasing decision, keep the published research and the supplied material distinct. The Peptides Collective vial is labelled 5000IU, with independent batch testing for purity and identity. ^[2][3] Those analytical checks do not establish equivalence to a clinical study's material or findings. ^[3]

HCG was associated with more ovarian hyperstimulation syndrome (OHSS) than a GnRH-agonist comparator in women undergoing fresh autologous IVF procedures, according to a 2014 Cochrane review. ^[10] The review covers human evidence, including 17 randomised controlled trials with 1,847 women undergoing IVF or ICSI. ^[10]

The OHSS comparison in that review used eight trials with 989 women. ^[10] GnRH agonists had a lower incidence of mild, moderate or severe OHSS than HCG, with an odds ratio of 0.15 and a 95% confidence interval of 0.05 to 0.47. ^[10] Keep that comparison attached to the fertility-study population; do not use it as an event-rate estimate for every HCG research setting.

The captured male studies report different observations:

• A 2019 retrospective human case series of 20 men with symptomatic hypogonadism reported no adverse events, PMID 31408289. ^[11]
• A 1998 open multicentre human study of 28 men with isolated hypogonadotropic hypogonadism, involving HCG and urinary FSH, recorded no serious study drug-related adverse events, PMID 9696217. ^[12]

The second statement concerns serious study drug-related events only. ^[12] Read both reports within their small male study populations and uncontrolled designs. They do not establish general safety. ^[11][12]

Peptides Collective's independent batch testing concerns analytical purity and identity. ^[3] Read a certificate for those laboratory measurements; keep clinical adverse-event findings attached to their study populations.

HCG is listed in Schedule 4 of Australia's Poisons Standard June 2026 as HUMAN CHORIONIC GONADOTROPHIN except in pregnancy test kits. ^[6] Schedule 4 is the prescription-only classification. ^[6] The checked status comes from instrument F2026L00633, verified in our compound record on 29 September 2026. ^[6]

An HCG-specific Appendix D listing was not confirmed in the supplied regulatory record. ^[6] The confirmed entry is Schedule 4 with the pregnancy-test-kit exception; an unconfirmed Appendix D check does not change that entry. ^[6] Our guide to Australian peptide law explains the scheduling framework.

The WADA 2026 status is: Prohibited at all times in males under S2.2.1 Testosterone-stimulating peptides (chorionic gonadotrophin, CG). ^[13] Both qualifiers matter: in males and at all times. ^[13] The verified rule is not limited to competition days. ^[13]

For the Peptides Collective HCG vial, use the named compound's dated legal status alongside its batch documentation. The certificate process checks purity and identity; it does not change the compound's scheduling. ^[3][6]

HCG laboratory handling starts with the batch record and its IU-labelled vial content, followed by a documented solvent, concentration and storage plan. ^[2][3][14] Peptides Collective's handling guides provide general laboratory guidance; they do not supply a validated stability study for this HCG formulation. ^[14][15]

Before reconstitution, request the certificate using the compound, strength and batch number. ^[3] The laboratory reconstitution guide describes checking the seal, cleaning stoppers, adding solvent down the glass wall and swirling gently. ^[14] Record the compound, batch number, solvent, concentration and preparation date on the laboratory label. ^[14]

HCG's vial is labelled in IU, so the captured guide expresses concentration in IU/mL. ^[2][14] Its example of a 5000IU vial with 2 mL solvent gives a nominal concentration of 2500 IU/mL. ^[14] Use the example for laboratory arithmetic only. It recommends no solvent and reports no measured activity for the batch.

The peptide storage guide recommends keeping dry material sealed, dry and away from light, and storing working solutions at 2 to 8°C. ^[15] Its guidance also calls for labelled vials and avoiding repeated freezing and thawing. ^[15] The two house guides differ on freezing preserved solutions, so they should not be read as a universal HCG freezing instruction. ^[14][15]

No HCG-specific solvent compatibility study, validated storage duration or product-specific expiry is supplied with these handling sources. ^[14][15] Obtain formulation-specific instructions with the batch documentation before choosing those conditions.

Peptides Collective supplies a 5000IU HCG vial with independent batch testing before sale: purity by HPLC and identity by mass spectrometry. ^[2][3] You can request the certificate for the batch using the compound, strength and batch number. ^[3]

Our testing information explains the analytical process, and the certificate of analysis page provides related certificate information. Request the certificate using the compound, strength and batch number. ^[3]

Dispatch is from Perth, Western Australia, twice daily Monday to Friday and once on Saturday. ^[3] Orders ship once payment clears, and every order is packed with thermal insulation in plain outer packaging. ^[3]

The Australian shipping information sets out the delivery options. Dispatch frequency and carrier estimates describe different stages: twice-daily dispatch is not a promise of same-day arrival. ^[3]

Choose the vial on the strength of the documented process: independent testing, a batch certificate on request and tracked Australian delivery from Perth. ^[3]

Choose Peptides Collective HCG 5000IU for a vial batch tested by an independent lab, with purity by HPLC, identity by mass spectrometry and a certificate on request. ^[2][3] Perth dispatch runs twice daily Monday to Friday, with WA courier free on orders over A$150. ^[3] Keep the batch report, formulation-specific handling information and dated Schedule 4 status together when planning laboratory procurement. ^[3][6][14]